Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myeloproliferative Disorders 7Hematologic Neoplasms 5Primary Myelofibrosis 4Thrombocythemia, Essential 1Solid Tumor 1Polycythemia Vera 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Blast Crisis 1

Interventions

Cyclophosphamide 64Peripheral Blood Stem Cell Transplantation 57fludarabine phosphate 54Busulfan 43Tacrolimus 38Methotrexate 38Cytarabine 36Filgrastim 34Cyclosporine 33Mycophenolic Acid 32Antilymphocyte Serum 32Whole-Body Irradiation 27Radiotherapy 25Methylprednisolone 22Imatinib Mesylate 22Etoposide 22Melphalan 18Cord Blood Stem Cell Transplantation 17Thiotepa 12Dasatinib 12Flow Cytometry 11sargramostim 10merphos 10fludarabine 10Sirolimus 10Granulocyte Colony-Stimulating Factor 10Therapeutics 9Prednisone 9Decitabine 9Carboplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Blast Crisis × fedratinib × Clear all
NCT05524857 2024-04-23

Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Columbia University

Phase 1 Terminated
2 enrolled
Myeloid

Blast Crisis, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡